Dodla margins crushed: consolidated PAT down 35% YoY to ₹41 Cr as milk costs surge
PAT -35.36% YoY · revenue +18.97% · margins compressing
₹1,197.94 Cr
+18.97% YoY
₹40.64 Cr
-35.36% YoY
3.35%
-2.8pp YoY
₹6.74
Dodla Dairy's Q1 FY27 consolidated revenue rose 19.0% YoY to ₹1,197.94 Cr, but net profit fell 35.4% to ₹40.64 Cr (and 41.7% sequentially from ₹69.73 Cr), with net margin compressing to 3.4% from 6.1% a year ago. There were no exceptional items on either side, so raw and adjusted YoY profit growth are identical — the decline is entirely operational. The headline topline is also flattered by consolidation of HR Food Processing (effective Aug 2025), which management itself flags renders the YoY numbers non-comparable; standalone revenue grew just 6.1% to ₹955.66 Cr.
Q1 FY-2027 vs prior quarters
The squeeze sits squarely on the raw-material line: consolidated cost of materials consumed jumped ~32% YoY to ₹940.61 Cr, far outpacing the 19% revenue rise, reflecting elevated milk procurement prices. The pain is starkest in the core standalone India business, where PAT collapsed 65% YoY to ₹21.75 Cr; overseas subsidiaries (₹210.28 Cr revenue, ₹18.23 Cr net profit) plus HR Food cushioned the group figure. That leaves a ~30-point gap between standalone (-65%) and consolidated (-35%) profit trends — readers should note the consolidated print understates how hard domestic dairy was hit.
The stock went into the print at ₹1,070, down 5.6% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
Consolidated EPS ₹6.74 vs ₹10.42 YoY — no exceptional items this quarter (Q4 FY26 had ₹3.21 Cr)
Management projects low to mid-teens revenue growth for FY27, supported by OSAM, continued Africa trajectory, and 8-9% organic growth in India. Gross margins are expected to recover by 50-100 basis points over FY26 due to normalizing procurement costs and pricing actions. Strategic direction focuses on funding growth c
— This quarter: missed
On the Q4 FY26 concall management guided to low-to-mid-teens FY27 revenue growth with a 50-100 bps gross-margin recovery as procurement costs normalized. Q1 delivers the topline (reported +19%, though inorganic; standalone +6% at the low end of the 8-9% organic India target) but decisively misses on margins — procurement costs rose rather than eased, directly contradicting the recovery thesis. No published street consensus for the quarter was found. Alongside results the board approved a ~2% minority stake in premium antibiotic-free D2C brand Sids Farm (FY26 turnover ₹240 Cr) for ₹11.65 Cr cash from internal accruals — immaterial to financials but consistent with the stated 'selective acquisitions' stance and a foothold in premium/D2C dairy. The earnings call is set for 27 July 2026.
W1
Milk procurement cost trajectory — cost of materials at ₹940.6 Cr (+32% YoY); management's guided 50-100 bps FY27 gross-margin recovery now directly in question
W2
Standalone India margin repair — standalone PAT down to ₹21.75 Cr; whether pricing actions restore the 6%+ NPM in coming quarters
W3
HR Food Processing contribution as the YoY base normalizes from Q2 FY27, when consolidated growth stops being flattered by the acquisition
Clean digital PDF; consolidated PAT ₹40.64 Cr fully attributable to shareholders (NCI nil). No exceptional items this quarter (Q4 FY26 had ₹3.21 Cr consol / ₹3.28 Cr standalone). Note 8: results not YoY-comparable due to HR Food Processing consolidation (eff. 1 Aug 2025). Company changed rounding to crores from millions this quarter. Standalone (-65% YoY PAT) and consolidated (-35%) diverge sharply.
Informational and educational content only. Not investment advice.